[1] |
Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options[J]. J Med Microbiol, 2013, 62(Pt 1): 10⁃24. DOI: 10.1099/jmm.0.045054⁃0.
|
[2] |
Fortún J, Martín⁃Dávila P, de la Pedrosa E G, et al. Emerging trends in candidemia: a higher incidence but a similar outcome[J]. J Infect, 2012, 65(1): 64⁃70. DOI: 10.1016/j.jinf.2012. 02.011.
|
[3] |
Smeekens SP, van de Veerdonk FL, Kullberg BJ, et al. Genetic susceptibility to Candida infections[J]. EMBO Mol Med, 2013, 5(6): 805⁃813. DOI: 10.1002/emmm.201201678.
|
[4] |
Gianchecchi E, Fierabracci A. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll⁃like receptors[J]. Autoimmun Rev, 2015, 14(11): 971⁃983. DOI: 10.1016/j.autrev.2015.07.006.
|
[5] |
Plantinga TS, Johnson MD, Scott WK, et al. Toll⁃like receptor 1 polymorphisms increase susceptibility to candidemia[J]. J Infect Dis, 2012, 205(6): 934⁃943. DOI: 10.1093/infdis/jir867.
|
[6] |
Woehrle T, Du W, Goetz A, et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans[J]. Cytokine, 2008, 41(3): 322⁃329. DOI: 10.1016/j.cyto.2007.12.006.
|
[7] |
Van der Graaf CA, Netea MG, Morré SA, et al. Toll⁃like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection[J]. Eur Cytokine Netw, 2006, 17(1): 29⁃34.
|
[8] |
Rosentul DC, Delsing CE, Jaeger M, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis[J]. Front Microbiol, 2014, 5: 483. DOI: 10.3389/fmicb.2014.00483.
|
[9] |
Nahum A, Dadi H, Bates A, et al. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity[J]. Autoimmun Rev, 2012, 11(5): 341⁃347. DOI: 10.1016/j.autrev.2011.10.007.
|
[10] |
Plantinga TS, Johnson MD, Scott WK, et al. Human genetic susceptibility to Candida infections[J]. Med Mycol, 2012, 50(8): 785⁃794. DOI: 10.3109/13693786.2012.690902.
|
[11] |
Taylor PR, Tsoni SV, Willment JA, et al. Dectin⁃1 is required for beta⁃glucan recognition and control of fungal infection[J]. Nat Immunol, 2007, 8(1): 31⁃38. DOI: 10.1038/ni1408.
|
[12] |
Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin⁃1 deficiency and mucocutaneous fungal infections[J]. N Engl J Med, 2009, 361(18): 1760⁃1767. DOI: 10.1056/NEJMoa0901053.
|
[13] |
Marakalala MJ, Kerrigan AM, Brown GD. Dectin⁃1: a role in antifungal defense and consequences of genetic polymorphisms in humans[J]. Mamm Genome, 2011, 22(1⁃2): 55⁃65. DOI: 10.1007/s00335⁃010⁃9277⁃3.
|
[14] |
Rosentul DC, Plantinga TS, Oosting M, et al. Genetic variation in the dectin⁃1/CARD9 recognition pathway and susceptibility to candidemia[J]. J Infect Dis, 2011, 204(7): 1138⁃1145. DOI: 10.1093/infdis/jir458.
|
[15] |
Usluogullari B, Gumus I, Gunduz E, et al. The role of human dectin⁃1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections[J]. Mol Biol Rep, 2014, 41(10): 6763⁃6768. DOI: 10.1007/s11033⁃014⁃3562⁃2.
|
[16] |
Plantinga TS, Hamza OJ, Willment JA, et al. Genetic variation of innate immune genes in HIV⁃infected african patients with or without oropharyngeal candidiasis[J]. J Acquir Immune DeficSyndr, 2010, 55(1): 87⁃94. DOI: 10.1097/QAI. 0b013e3181e53c64.
|
[17] |
Garred P, Larsen F, Seyfarth J, et al. Mannose⁃binding lectin and its genetic variants[J]. Genes Immun, 2006, 7(2): 85⁃94. DOI: 10.1038/sj.gene.6364283.
|
[18] |
van Till JW, Modderman PW, de Boer M, et al. Mannose⁃binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis[J]. Clin Vaccine Immunol, 2008, 15(1): 65⁃70. DOI: 10.1128/CVI.00297⁃07.
|
[19] |
Nedovic B, Posteraro B, Leoncini E, et al. Mannose⁃binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta⁃analysis[J]. Biomed Res Int, 2014, 2014: 738298. DOI: 10.1155/2014/738298.
|
[20] |
Donders GG, Babula O, Bellen G, et al. Mannose⁃binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis[J]. BJOG, 2008, 115(10): 1225⁃1231. DOI: 10.1111/j.1471⁃0528.2008.01830.x.
|
[21] |
Diller ML, Kudchadkar RR, Delman KA, et al. Balancing inflammation: the link between Th17 and regulatory T cells[J]. Mediators Inflamm, 2016, 2016: 6309219. DOI: 10.1155/2016/6309219.
|
[22] |
Fierabracci A, Bizzarri C, Palma A, et al. A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy⁃candidiasis⁃ectodermal dystrophy syndrome (APECED)[J]. Gene, 2012, 511(1): 113⁃117. DOI: 10.1016/j.gene.2012.09.029.
|
[23] |
Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin⁃17 immunity[J]. Science, 2011, 332(6025): 65⁃68. DOI: 10.1126/science.1200439.
|
[24] |
Liu L, Okada S, Kong XF, et al. Gain⁃of⁃function human STAT1 mutations impair IL⁃17 immunity and underlie chronic mucocutaneous candidiasis[J]. J Exp Med, 2011, 208(8): 1635⁃1648. DOI: 10.1084/jem.20110958.
|
[25] |
Johnson MD, Plantinga TS, van de Vosse E, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study[J]. Clin Infect Dis, 2012, 54(4): 502⁃510. DOI: 10.1093/cid/cir827.
|
[26] |
Sun RT, Tian WJ, Xing XW, et al. Association of cytokine gene polymorphisms with susceptibility to invasive candidiasis[J]. Genet Mol Res, 2015, 14(2): 6859⁃6864. DOI: 10.4238/2015.June.18.29.
|
[27] |
Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections[J]. N Engl J Med, 2009, 361(18): 1727⁃1735. DOI: 10.1056/NEJMoa0810719.
|
[28] |
Jaeger M, Carvalho A, Cunha C, et al. Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(5): 797⁃801. DOI: 10.1007/s10096⁃016⁃2600⁃5.
|